Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Im very concerned why there is no mention on the Avacta website about covid testing. The optimistic view is. 1. They have a update ready but can only update after rns is out. But the other side of the fence we have 1. The test has failed and they have now given up. BAMS hasnt taken off, saliva was rejected, to date nothing they have done has really worked. 2. They are done trying to make their own test and will leave it to mologic and bruker to see what they can achieve.
Is their a chance that Avacta could offer the affimers at cost for the gov deals. I'm just thinking are their scenarios where Affimers work, but the market gets disappointed with the deal eg like how ODX winning the tender but using borrowed equipment/low margin. Or do we think any clinical validation will push us higher regardless of the numbers.
Pl why do you think we will get £7 per test. I'd say we will only get the cost of an affimer as we are not the manufacturer. Conservatively I'd say £1 a test for 1 affimer = £10m pm. 120m per yr x 5 multiple = £600m market cap on lft alone.
It's really annoying that Avacta were working on saliva first and the gov made them change. Then avacta pointed out issues with PD clinical validation not using real patient samples. They know more than the Gov. If avacta had gone about their business we probably would have a working saliva test out now. Hopefully its easy to being it out, but then again we are in Q2 and still no lft test :(
Is it TRUE the ODX director sold his shares to buy £14m Avacta shares today?
Will be the same ritual. Will wake up early, roll over to my phone, open my eye slightly, as the light is too strong, somehow type avacta lse with this blurred vision, see there is no number next to rns, swear, go back to sleep. Then when fully awake, will deal with another margin call and freak out.